#LobMob
"Patient advocates are research partners. We can provide the scientific expertise; they provide the lived experience. Patients are really the ones responsible for making #ILC visible to the research community." - Dr. Mo Rimawi

Hear hear!!!
#ILCSymposium #lobmob @lobularbca.bsky.social
September 25, 2026 at 12:03 AM
Dr. Karen van Baelen looked at modifiable risk factors in #ILC recurrence. Physical activity once again shown to be beneficial for #breastcancer patients! #ILCSymposium #lobmob #bcsm #exerciseismedicine
September 24, 2026 at 8:53 PM
Guilford breaks down clinical management of hereditary diffuse #gastriccancer which is intense. Patients often have their stomachs removed, which comes w/ many adverse effects (& a few bennies, he noted, tongue firmly in cheek). #ILCSymposium #HDGC #lobmob #bcsm
September 24, 2026 at 7:02 PM
Guilford proposes using the term hereditary diffuse gastric & #lobular #breastcancer syndrome for those w/ #CDH1 mutation since many people who survive #gastric #cancer will develop #lobularBC. #ILCSymposium @lobularbca.bsky.social @elbcc-2018.bsky.social #bcsm #lobmob
September 24, 2026 at 6:54 PM
Dr. Rachel Jankowitz talks about #lobular #breastcancer in premenopausal patients. Stays say 80-85% of ILC pts are postmenopausal; 10-15% are premenopausal. BUT at UCSF, 28% of #ILC pts were premenopausal; at Penn, 35% of ILC pts were premenopausal. #ILCSymposium @lobularbca.bsky.social #lobmob
September 24, 2026 at 8:37 PM
The #ILCSymposium kicks off in San Francisco w/an advocate session led by @lobularbca.bsky.social advocates and Dr. Rita Mukhtar. #CanSky #bcsm #lobmob
September 23, 2026 at 3:55 PM
Great advocacy session this morning at the #ILCSymposium in San Francisco w/advocates from around the world. Here @clairehudson.bsky.social from @lobularbcuk.bsky.social talks about how to make it easier 4 #lobularBC patients to join #clinicaltrials. #CanSky #bcsm #lobmob
September 23, 2026 at 6:06 PM
That's awful. I'm sorry, LobMob. Sending the healing vibes.
August 30, 2026 at 2:21 AM
May the Fourth be with you.

Carved in my memory and on my chest, it's my seventh mastectoversary.

A tough old road, but still here.
#ThanksCancer #BreastCancer #LobMob #Lobular #ILC #CanSky
May 4, 2025 at 8:48 AM
Happy #Cancerversary from another member of the #LobMob
So glad you are here.
February 12, 2025 at 4:21 PM
I write a bit of poetry to get me through. On Insta @moon_dream_poetry
#cansky #thankscancer #lobmob #writingistherapy #poetry
December 6, 2024 at 7:15 PM
I don’t know if it’s the Verzenio, or the Exemestane, or the pain in my arm from lymphedema, or the cumulative effects of 27 months of active cancer treatment, but I feel extra crappy today.

#cansky #bcsm #lobmob #thankscancer #fatigue
#jointpain
November 27, 2024 at 9:57 PM
Lobular breast cancer is a sneaky bastard so I recently had my 2nd FES PET/CT. Negative for recurrence. Positive for pneumonia. I’ll take it. 🩻

#cansky #lobmob #cancersux #breastcancer #scanxiety #radiologyregular
November 26, 2024 at 5:52 AM
Thanks LobMob! I wish you a rich and productive Saturday!
March 22, 2025 at 5:44 PM
Coming right up Wed Oct 15! 👀

Join me & other #lobmob members 4 #ILC insights from @fredhutch.org #lobular #breastcancer experts Chris Li, Hannah Linden & Diana Lam. #CanSky @elbcc-2018.bsky.social 👇
Spotlight on lobular #BC: What pts, PCPs & oncologists need to know
share.google/Lx4Fcu6Ar7mu...
October 10, 2025 at 1:52 AM
" ... facilitate treatment efficacy & lead 2 better understanding of metastatic mechanisms, thus improving outcomes 4 the increasing number of affected women." 2/2 #CanSky #lobmob @lobularbca.bsky.social

Thank you @americancancersoc.bsky.social
acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
Lobular breast cancer statistics, 2025
Invasive lobular carcinoma is the second most common breast cancer subtype in the United States, with unique clinical characteristics that distinguish it from the more common ductal carcinoma. Despit....
acsjournals.onlinelibrary.wiley.com
October 8, 2025 at 3:24 PM
Curious abt #lumpless #lobular #breastcancer? I'm hosting this event on Wed, Oct 15, 3-5 pm at #FredHutch @fredhutch.org in #Seattle w/Drs. Chris Li, Hannah Linden & Diana Lam. Learn abt #lobularBC history #imaging issues, new research & #CTs! #lobmob #CanSky @thankscancer.bsky.social #bcsm #lbca
Spotlight on lobular breast cancer: What patients, PCPs & oncologists need to know
Hear from Fred Hutch experts about lobular breast cancer’s history, screening and surveillance challenges, new findings and clinical trials.
www.fredhutch.org
September 27, 2025 at 8:03 PM
Thanks so much! Strange times but I'm still trying to do what I can to help people out there avoid #cancer & help those dealing with it, to get through. #CanSky #MedSky #FUcancer #lobmob
February 12, 2025 at 4:25 PM
Thanks so much and great to hear from another member of the #lobmob!!
#cansky #bcsm

Long live us all!!! 😎❤️💪
February 12, 2025 at 6:05 AM
The Alamo #BreastCancer Foundation's Hot Topics panel at #SABCS24 always rocks, especially when you have top researchers like our "lobmother" Dr. Steffi Oesterreich. #cansky #oncosky #lobmob
December 13, 2024 at 12:12 AM
Up now, Dr. Otto Metzger presenting on the PATINA trial. Not a #lobular #breastcancer study but he's a #lobmob rock star. #sabcs24 #cansky #oncosky @lobularbccanada.bsky.social
December 12, 2024 at 5:52 PM
So excited! Just saw my 1ST poster w/ #lobular #breastcancer broken out from #ductal (NST) #BC. TY🙏Eleanor Taranto & the #SURMOUNT study folks 4 recognizing the importance of stratifying us into our respective #cancer subtypes so all are served by the science. #sabcs24 #cansky #oncosky #bcsm #lobmob
December 12, 2024 at 1:21 PM
Poster sessions are the best, especially when you run into rock star #cancer researchers & patient advocates like @mattsikora.bsky.social @itsnotpink.bsky.social & @christeeny513.bsky.social. #sabcs24 #cansky #oncosky @graspcancer.bsky.social #lobularBC #lobmob
December 12, 2024 at 4:45 AM
This is huge ... Esp for #lobularBC which can be hard to image in mets. #sabcs24 #cansky #lobmob
Intriguing data presented by @lfoffano.bsky.social at the #SABCS24 poster session on how #ctDNA can be leveraged to enhance disease monitoring in metastatic #BreastCancer.

Paving the way to a new #liquidbiopsy informed RECIST

#PrecisionMedicine #bcsm
December 11, 2024 at 11:30 PM
Sweet specialty cocktails in honor of #SABCS24 the San Antonio #BreastCancer Symposium. I'll be trackng @fredhutch.bsky.social research as well as new findings in the world of no-lump #lobulatBC. Looking forward 2 seeing my peeps & learning the latest on kicking #BCs butt. #cansky #oncosky #lobmob
December 10, 2024 at 2:47 AM